All In Biotech

Drug Trial Radar · NCT07300839

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL STUDY EVALUATING THE SAFETY, TOLERABILITY, IMMUNOGENICITY AND EFFICACY OF A VARIANT-ADAPTED BNT162B2 VACCINE IN HEALTHY PARTICIPANTS 50 THROUGH 64 YEARS OF AGE

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 5,240 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

5,240

Actual

Start

Dec 10, 2025

Primary completion

Sep 22, 2026

Study completion Sep 22, 2026

Sponsor

Lead sponsor
BioNTech SEIndustry
Sponsor type
Industry
Collaborators
Pfizer
First posted
Dec 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 64 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

Conditions

  • COVID-19
  • SARS-COV-2 Infection

Interventions

  • BNT162b2 VaccineBiological

    Single dose

  • PlaceboBiological

    Single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants reporting local reactions or systemic eventsTime frame: From Day 1 up to 7 days after Vaccination
  2. Percentage of participants reporting adverse eventsTime frame: From Day 1 through 4 weeks after vaccination
  3. Percentage of participants reporting serious adverse eventsTime frame: From Day 1 through 6 months after vaccination
  4. First episode of confirmed COVID-19 casesTime frame: From 0 days after vaccination through end of COVID-19 surveillance at least 6 months post-vaccination

Locations

196 sites in 1 country. Site status is shown where the registry gives one.

  • Pinnacle Research Group, LLC

    Anniston, Alabama

  • North Alabama Research Center

    Athens, Alabama

  • Simon Williamson Clinic / Synexus Clinical Research US, Inc.

    Birmingham, Alabama

  • Accel Research Sites - Birmingham Clinical Research Unit

    Birmingham, Alabama

  • Cullman Clinical Trials

    Cullman, Alabama

  • AMR Clinical

    Daphne, Alabama

  • Medical Affiliated Research Center

    Huntsville, Alabama

  • AMR Clinical

    Mobile, Alabama

  • Chandler Clinical Trials

    Chandler, Arizona

  • Scottsdale Clinical Trials

    Scottsdale, Arizona

  • Epic Medical Research-Sun City

    Sun City, Arizona

  • Noble Clinical Research

    Tucson, Arizona

  • Synexus Clinical Research US, Inc./Orange Grove Family Practice

    Tucson, Arizona

  • Woodland International Research Group, LLC

    Little Rock, Arkansas

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • Velocity Clinical Research, Chula Vista

    Chula Vista, California

  • West Coast Research

    Dublin, California

  • Triallogix Medical Corporation

    Fullerton, California

  • Upper Echelon Medical

    Fullerton, California

  • Marvel Clinical Research

    Huntington Beach, California

  • Eximia Research-CA, LLC

    La Mesa, California

  • Velocity Clinical Research, Los Angeles

    Los Angeles, California

  • Leading Edge Research

    Los Angeles, California

  • ImmuniMet

    Modesto, California

  • Carbon Health - North Hollywood - NoHo West

    North Hollywood, California

  • Empire Clinical Research

    Pomona, California

  • Peninsula Research Associates

    Rolling Hills Estates, California

  • Northern California Research - Sacramento

    Sacramento, California

  • Velocity Clinical Research, San Bernardino

    San Bernardino, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc.

    Toluca Lake, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Legacy Clinical Trials

    Colorado Springs, Colorado

  • Tekton Research, LLC.

    Fort Collins, Colorado

  • Tekton Research, LLC.

    Longmont, Colorado

  • Paradigm Clinical Research Centers, LLC

    Wheat Ridge, Colorado

  • Clinical Research Consulting

    Milford, Connecticut

  • Stamford Therapeutics Consortium

    Stamford, Connecticut

  • Washington Health Institute

    Washington D.C., District of Columbia

  • International Clinical Research - FL, LLC

    Altamonte Springs, Florida

Showing 40 of 196 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.